SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2184331

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2184331

Monoclonal Antibody Diagnostic Reagents Market, By Diagnostic tests, By Application, By Geography

PUBLISHED:
PAGES: 254 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Monoclonal Antibody Diagnostic Reagents Market is estimated to be valued at USD 10.6 Bn in 2026 and is expected to reach USD 24.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 10.6 Bn
Historical Data for: 2020 to 2024 Forecast Period: 2026 to 2033
Forecast Period 2026 to 2033 CAGR: 10.60% 2033 Value Projection: USD 24.7 Bn

The market is experiencing significant growth due to the increasing demand for accurate disease detection, rising adoption of immunoassay-based diagnostic technologies, growing prevalence of chronic and infectious diseases, and advancements in monoclonal antibody development. Monoclonal antibody diagnostic reagents are widely used in clinical diagnostics, disease screening, biomarker detection, and laboratory testing to identify specific antigens and disease-associated proteins. The market includes various diagnostic testing methods, such as Dot-immunogold Filtration Assay, Double Antigen Sandwich Chemiluminescence Method, Enzyme Linked Immunosorbent Assay, and Recombinant Immunoblot Assay.

Healthcare providers and diagnostic laboratories are increasingly adopting monoclonal antibody-based reagents to improve testing accuracy, enhance early disease detection, and support clinical decision-making. Advancements in antibody engineering, automated immunoassay platforms, and point-of-care diagnostic technologies are improving test sensitivity, specificity, and operational efficiency. In addition, the growing use of monoclonal antibodies in hormone diagnosis, tumor monitoring, and viral detection is expanding their clinical applications. Increasing investments in biotechnology research, laboratory infrastructure, and precision medicine are further supporting market expansion across developed and emerging economies.

Market Dynamics

The market is witnessing significant momentum owing to the increasing prevalence of cancer, infectious diseases, and endocrine disorders, along with the growing demand for sensitive and reliable diagnostic testing solutions. Market growth is largely driven by healthcare providers seeking accurate disease identification, early diagnosis, and improved treatment monitoring. Monoclonal antibody-based diagnostic reagents play an important role in detecting specific biomarkers and disease-associated antigens, particularly in hormone diagnosis, tumor monitoring, and viral detection. The increasing adoption of automated immunoassays, rapid diagnostic tests, and point-of-care testing platforms is strengthening demand for these reagents across hospitals, diagnostic laboratories, and research institutions.

The expansion of diagnostic laboratory infrastructure and biotechnology research activities is further supporting market growth. This is mainly driven by increasing investment in immunodiagnostic technologies, advancements in antibody engineering, and the growing development of companion diagnostics for precision medicine. Diagnostic methods such as Dot-immunogold Filtration Assay, Enzyme Linked Immunosorbent Assay, and chemiluminescence-based testing are gaining importance because of their ability to support disease screening and biomarker identification. However, high development and validation costs, stringent regulatory requirements, and the need for consistent reagent quality may limit adoption among smaller diagnostic manufacturers and laboratories.

The rising focus on personalized medicine and early disease detection is also creating new growth opportunities. Diagnostic reagent manufacturers, biotechnology companies, clinical laboratories, and research organizations play a crucial role in developing and commercializing monoclonal antibody-based testing solutions. As demand for accurate diagnostic technologies continues to increase, the market is expected to benefit from advancements in antibody specificity, improved assay performance, expanding healthcare access, and the growing integration of immunodiagnostic technologies into routine clinical testing.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Monoclonal Antibody Diagnostic Reagents Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AnaSpec, BioGenex, Bio-Rad, Biocare Medical, BioVision, Celltrion, Creative Diagnostics, GenWay Biotech, Innovent Biologics, Medix Biochemica, Qiagen, and Teva Pharmaceutical Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Monoclonal Antibody Diagnostic Reagents Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Monoclonal Antibody Diagnostic Reagents Market

Market Segmentation

  • By Diagnostic tests (Revenue, USD Bn, 2021-2033)
  • Dot-immunogold Filtration Assay
  • Double Antigen Sandwich Chemiluminescence Method
  • Enzyme Linked Immunosorbent Assay
  • Recombinant Immunoblot Assay
  • By Application (Revenue, USD Bn, 2021-2033)
  • Hormones Diagnosis
  • Tumor Monitoring
  • Virus Detection
  • Other Applications
  • By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
  • AnaSpec
  • BioGenex
  • Bio-Rad
  • Biocare Medical
  • BioVision
  • Celltrion
  • Creative Diagnostics
  • GenWay Biotech
  • Innovent Biologics
  • Medix Biochemica
  • Qiagen
  • Teva Pharmaceutical Ltd.
Product Code: CMI2048

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Diagnostic Tests
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Monoclonal Antibody Diagnostic Reagents Market, By Diagnostic Tests, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Dot-immunogold Filtration Assay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Double Antigen Sandwich Chemiluminescence Method
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Enzyme Linked Immunosorbent Assay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Recombinant Immunoblot Assay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Monoclonal Antibody Diagnostic Reagents Market, By Application, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hormones Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Tumor Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Virus Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Monoclonal Antibody Diagnostic Reagents Market, By Region, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tests, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tests, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tests, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tests, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tests, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tests, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • AnaSpec
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • BioGenex
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Bio-Rad
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Biocare Medical
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • BioVision
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Celltrion
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Creative Diagnostics
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • GenWay Biotech
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Innovent Biologics
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Medix Biochemica
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Qiagen
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Teva Pharmaceutical Ltd
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!